Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-21

FDA Approved: NEVIRAPINE — Supplemental Application (Micro Labs Limited)

View source ↗

Summary

FDA approved a supplemental application for NEVIRAPINE from Micro Labs Limited (ANDA 203080), authorizing a generic NEVIRAPINE product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEVIRAPINE (nevirapine)

Snippet

SUPPL AP for NEVIRAPINE (NEVIRAPINE)